The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

All agenciesFDA (Food)FDA (Drugs)FDA (Devices)USDA FSISCPSCNHTSAEPA

Category

All categoriesFoodDrugMedical DeviceVehicleConsumer Product

Minimum severity

Any3+ (High and above)4+ (High and above)5+ (High and above)

Clear filters

14376–14400 of 17799

  • ModerateFDA (Drugs)·D-0411-2015·2015-03-18

    Qualitest Recalls Promethazine DM Syrup Due to Plastic Particulates

    Qualitest Pharmaceuticals is recalling 972 bottles of Promethazine DM Syrup because plastic cap closure particulates may be present in the product.

    Product
    PROMETHAZINE DM SYRUP (Promethazine Hydrochloride, USP and Dextromethorphan Hydrobromide, USP), EACH 5 ml (ONE TEASPOONFUL) CONTAINS: Promethazine Hydrochloride 6.25 mg, Dextromethorphan Hydrobromide 15 mg, alcohol 7%, ONE PINT (574 mL), Rx only, Manufactured for: QUALITEST…
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0407-2015·2015-03-18

    Micro Labs Recalls Simvastatin Tablets Due to Impurity Failure

    Micro Labs USA Inc. is recalling specific lots of Simvastatin Tablets, 20mg, because the product failed a known impurity specification.

    Product
    Simvastatin Tablets, USP, 20mg a) 90- count bottle (42517-0020-10), b) 1000-count-bottle (NDC 42571-0020-10), Rx only, Manufactured by: Micro Labs Limited Goa-403 722, India, Manufactured for: Micro Labs USA Inc.,Princeton, NJ 08540
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0398-2015·2015-03-11

    Sagent Pharmaceuticals Recalls Atracurium Besylate Injection Due to Sterility Concerns

    Sagent Pharmaceuticals is recalling Atracurium Besylate Injection vials because FDA observations regarding aseptic and GMP practices at the manufacturing site may have impacted product sterility.

    Product
    Atracurium Besylate Injection, USP, 50 mg per 5 mL (10 mg per mL), Rx Only, 5 mL Single-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-659-05
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0406-2015·2015-03-11

    Actavis Recalls Vancomycin Hydrochloride Capsules Due to Subpotent Drug

    Actavis Inc. is voluntarily recalling 29,405 cartons of Vancomycin Hydrochloride Capsules, USP, 250 mg, because the drug was found to be subpotent.

    Product
    Vancomycin Hydrochloride Capsules, USP, 250 mg, 2 x 10 count blister pack, Rx Only, Manufactured for Watson Pharma Inc., Parsippany, NJ 07054, by Patheon Pharmaceuticals Inc., Cincinnati, OH. NDC 0591-3561-15
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0399-2015·2015-03-11

    Sagent Pharmaceuticals Recalls Atracurium Besylate Injection Due to Sterility Concerns

    Sagent Pharmaceuticals is recalling Atracurium Besylate Injection vials because FDA observations suggest potential impacts on product sterility.

    Product
    Atracurium Besylate Injection, USP, 100 mg per 10 mL (10 mg per mL), Rx Only, 10 mL Multi-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-672-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0396-2015·2015-03-11

    Actavis Recalls Subpotent Vancomycin Hydrochloride Capsules Nationwide

    Actavis Inc. is voluntarily recalling 51,472 cartons of Vancomycin Hydrochloride Capsules, USP, 125 mg, because the drug is subpotent.

    Product
    Vancomycin Hydrochloride Capsules, USP, 125 mg, 2 x 10 count blister pack, Rx Only, Manufactured for Watson Pharma Inc., Parsippany, NJ 07054, by Patheon Pharmaceuticals Inc., Cincinnati, OH. NDC 0591-3560-15
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0405-2015·2015-03-11

    Akorn Recalls Fluticasone Nasal Spray Due to Preservative Failure

    Akorn, Inc. is recalling Fluticasone Propionate Nasal Spray because the preservative benazalkonium chloride failed to meet stability specifications.

    Product
    Fluticasone Propionate Nasal Spray, USP, 50 mcg per spray, in amber glass bottle with net fill weight of 16 g that provides 120 actuations, Rx only, Manufactured by HI-TECH PHARMACAL CO., INC. Amityville, NY 11701 for Akorn Inc. 1925 W. Field Court, Suite 300 Lake Forest…
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0397-2015·2015-03-11

    Qualitest Recalls Amlodipine Besylate Tablets Due to Oversized Size

    Qualitest Pharmaceuticals is recalling 2,808 bottles of Amlodipine Besylate tablets because one lot contains oversized tablets.

    Product
    AMLODIPINE BESYLATE TABLETS USP, 10 mg*, 1000 count bottles (NDC 0603-2110-32), Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0404-2015·2015-03-11

    Pfizer Recalls Oxecta Tablets Due to Failed Impurity Specifications

    Pfizer is recalling 139 bottles of Oxecta (oxycodone HCl) 7.5 mg tablets because they failed impurity and degradation specifications.

    Product
    Oxecta(TM) (oxycodone HCl) tablets, 7.5 mg, 100 count bottles, Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc. Bristol, TN, NDC 60793-526-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0395-2015·2015-03-11

    Actavis Recalls Dextroamphetamine Sulfate Capsules for Dissolution Failures

    Actavis Elizabeth LLC is recalling 42 bottles of Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg, because they failed dissolution specifications.

    Product
    DEXTROAMPHETAMINE SULFATE — DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0403-2015·2015-03-11

    Pfizer Recalls Oxecta Tablets Due to Failed Impurity Specifications

    Pfizer is recalling 137 bottles of Oxecta (oxycodone HCl) 5 mg tablets because they failed impurity and degradation specifications.

    Product
    Oxecta(TM) (oxycodone HCl) tablets, 5 mg, 100 count bottles, Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc. Bristol, TN, NDC 60793-525-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0402-2015·2015-03-11

    AvKARE Recalls Subpotent Quinapril Tablets Due to Low Drug Content

    AvKARE Inc. is voluntarily recalling 431 unit dose packs of Quinapril Tablets USP, 40 mg, because the medication was found to be subpotent.

    Product
    Quinapril Tablets USP, 40 mg, Rx only, 50 tablets (5 X 10) unit dose pack, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, UPC 5026869115, NDC 50268-691-15
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0401-2015·2015-03-11

    AvKARE Recalls Subpotent Quinapril Tablets Due to Low Dosage

    AvKARE Inc. is voluntarily recalling 214 unit dose packs of Quinapril 5 mg tablets nationwide because the medication is subpotent.

    Product
    Quinapril Tablets USP, 5 mg, Rx only, 50 tablets (5 X 10) unit dose pack, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, UPC 5026868815, NDC 50268-688-15
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0400-2015·2015-03-11

    Nanophase Technologies Recalls Z-COTE HP 1 Transparent Zinc Oxide Powder

    Nanophase Technologies is recalling 4,104 cartons of Z-COTE HP 1 Transparent Zinc Oxide powder due to illegible labels where writing is rubbing off.

    Product
    Z-COTE HP 1 TRANSPARENT ZINC OXIDE, Zinc Oxide (and) Triethoxycaprylylsilane, powder, Net: 22 kg, Packaged in double plastic liners in a single fiber carton, For manufacturing, processing, or repackaging. Nano Technologies Corporation 1319 Marquettte Drive, Romeoville, IL 60446.…
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0393-2015·2015-03-04

    Par Pharmaceutical Recalls Mafenide Acetate Topical Solution Due to Foreign Substances

    Par Pharmaceutical Inc. is recalling Mafenide Acetate 5% Topical Solution packets due to the presence of oxidized steel, organic material, and shredded polypropylene.

    Product
    Mafenide Acetate, USP, For 5% Topical Solution, STERILE, Net Wt. 50 grams sterile powder per packet, Rx only, PAR Pharmaceuticals label --- Distributed by: Par Pharmaceutical Companies, Inc. Spring Valley, NY 10977 Made in India -- NDC 49884-902-52 (packets of 50 g) and NDC…
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0394-2015·2015-03-04

    Sun Pharma Recalls Ketorolac Ophthalmic Solution Due to Particulate Matter

    Sun Pharma Global Fze is recalling specific bottles of Ketorolac Tromethamine Ophthalmic Solution because the product contains particulate matter exceeding specification limits.

    Product
    Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 3 mL bottle, Rx only, Distributed by: Caraco Pharmaceutical Laboratories Ltd., 1150 Elijah Mccoy Drive, Detroit, MI 48202; Manufactured at: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India; NDC…
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0392-2015·2015-02-25

    Hospira Recalls Lactated Ringer's Injection Due to Confirmed Mold Particulates

    Hospira Inc. is recalling 142,644 bags of Lactated Ringer's and 5% Dextrose Injection USP due to confirmed mold particulates in the solution.

    Product
    LACTATED RINGER'S and 5% DEXTROSE Injection USP, 1000 mL, flexible containers, Rx Only, Hospira, Inc., Lake Forest, IL 600045, NDC 0409-7929-09
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0391-2015·2015-02-25

    Hospira Recalls Lidocaine Hydrochloride Injection Due to Particulate Matter

    Hospira is recalling specific vials of 1% Lidocaine Hydrochloride Injection because a returned sample contained human hair attached to the stopper.

    Product
    LIDOCAINE HYDROCHLORIDE — LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0387-2015·2015-02-25

    Hospira Recalls Vancomycin Hydrochloride Injection Due to Temperature Abuse

    Hospira Inc. is recalling specific lots of Vancomycin Hydrochloride for Injection because they experienced uncontrolled temperature excursions during transit.

    Product
    VANCOMYCIN HYDROCHLORIDE — VANCOMYCIN HYDROCHLORIDE (VANCOMYCIN HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0388-2015·2015-02-25

    Hospira Recalls Ketorolac Tromethamine Injections Due to Temperature Abuse

    Hospira Inc. is recalling 100 vials of Ketorolac Tromethamine Injection due to uncontrolled temperature excursions during transit. The product was limited to one shipment to a distributor.

    Product
    KETOROLAC TROMETHAMINE — KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0390-2015·2015-02-25

    Hospira Recalls Vancomycin Hydrochloride Injection Due to Temperature Excursions

    Hospira Inc. is recalling 90,600 vials of Vancomycin Hydrochloride for Injection because the products experienced uncontrolled temperature excursions during transit.

    Product
    VANCOMYCIN HYDROCHLORIDE — VANCOMYCIN HYDROCHLORIDE (VANCOMYCIN HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0385-2015·2015-02-18

    Akorn Recalls Erythromycin Pledgets Due to Microbial Contamination

    Akorn, Inc. is recalling Erythromycin Pledgets USP, 2%, 60-count jars because the active pharmaceutical ingredient failed USP microbial tests.

    Product
    Erythromycin Pledgets USP, 2%, 60-count jar,Rx only, Manufactured by Ei LLC, Kannapolis, NC 28083, Marketed by VersaPharm Incorporated, Marietta, GA 30062, NDC 61748-202-60 .
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D0384-2015·2015-02-18

    AnazaoHealth Recalls Compounded Plaquex Intravenous Injection Due to Unapproved Ingredient Source

    AnazaoHealth Corporation is recalling 51 vials of Compounded Plaquex intravenous injection nationwide because the product contains an active pharmaceutical ingredient from an unapproved source.

    Product
    Compounded Plaquex, intravenous injection, 50 ML vial. Each ml contains: Phosphatidyl Choline 50 mg, Sodium Deoxycholate 25 mg, Benzyl Alcohol 0.9%, Ethanol (95%) 2.4 mg di Alpha Tocopheryl Acetate 0.2 mg in Sterile Water for injection.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0386-2015·2015-02-18

    Sun Pharma Recalls Levetiracetam Extended Release Tablets for Dissolution Failure

    Sun Pharma Global Fze is recalling 3,263 bottles of Levetiracetam extended release tablets because they failed to meet dissolution specifications at the 6-month time point.

    Product
    Levetiracetam, extended release tablets, 750 mg, 60-count bottle, Rx only, Manufactured by Sun Pharmaceutical Ind. Ltd Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC Number: 47335-576-86
    Category
    Drug
    Distribution
    Distributed nationwide